# Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis

> **NCT05912946** · PHASE2,PHASE3 · UNKNOWN · sponsor: **West China Hospital** · enrollment: 129 (estimated)

## Conditions studied

- Interstitial Cystitis

## Interventions

- **DRUG:** Interferon
- **DRUG:** Sodium Hyaluronate
- **DRUG:** Sodium Chloride Injection

## Key facts

- **NCT ID:** NCT05912946
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-15
- **Primary completion:** 2024-10-15
- **Final completion:** 2024-10-15
- **Target enrollment:** 129 (ESTIMATED)
- **Last updated:** 2023-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05912946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05912946, "Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05912946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*